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Abstract
Introduction and hypothesis Midstream urine (MSU) is key in assessing lower urinary tract syndrome (LUTS), but contingent
on some assumptions. The aim of this study was to compare the occurrence of contamination and the quality of substrates
obtained from four different collections: MSU, catheter specimen urine (CSU), a commercial MSU collecting device (Peezy) and
a natural void. Contamination was quantified by differential, uroplakin-positive, urothelial cell counts.
Methods This was a single blind, crossover study conducted in two phases. First, we compared the MSU with CSU using urine
culture, pyuria counts and differential counting of epithelial cells after immunofluorescence staining for uroplakin III (UP3).
Second, we compared the three non-invasive (MSU, Peezy MSU™, natural void) methods using UP3 antibody staining only.
Results The natural void was best at collecting bladder urinary sediment, with the majority of epithelial cells present derived from
the urinary tract. CSU sampling missed much of the urinary sediment and showed sparse culture results. Finally, the MSU
collection methods did not capture much of the bladder sediment.
Conclusion We found little evidence for contamination with the four methods. Natural void was the best method for harvesting shed
urothelial cells and white blood cells. It provides a richer sample of the inflammatory exudate, including parasitised urothelial cells and
the microbial substrate. However, if the midstream sample is believed to be important, the MSU collection device is advantageous.
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Introduction
A urinary tract infection (UTI) is the leading reason why pa-
tients seek treatment in primary care [1]. One in three women
will be treated with antibiotics for UTI by the age of 24 and
40% to 50% of women will experience one or more UTIs in
their lifetime, with 10–15% experiencing recurrent infections
[2]. A UTI is commonly identified among young adolescents
attending sexual health centres and accounts for 17% of treat-
ment cases [3]. In the adult population of 65 years and older, a
UTI is the second most common cause of infectious disease
related to hospitalisations in the USA [4]. A UTI is a debili-
tating condition causing the onset of painful urination (dys-
uria), increased urinary frequency, the inability to start urinat-
ing (hesitancy) and the sensation of a sudden need to urinate
(urgency) [5], all of which are classified as lower urinary tract
symptoms (LUTS) [6].
Many clinical guidelines advocate urinary dipstick testing
for leucocyte esterase and nitrite as a means of detecting UTI,
but evidence suggests that their utility might be limited [7].
Dipstick analyses are surrogate tests, referenced not to micro-
scopic pyuria but to a gold standard urine culture threshold for
UTI, which guidelines accept as being between 103 cfu ml−1
and 106 cfu ml−1 of the pure growth of a single urinary path-
ogen [8]. This test has attracted criticism too [9–11].
Furthermore, the literature shows that the methods of sample
collection for urine culture have never been validated in ap-
propriate clinical trials. Justification for the use of such
methods is based on plausible assumptions without supporting
evidence. It is now recognised that routine urinalyses, includ-
ing dipstick and culture, are insensitive, thus missing genuine
infection in many symptomatic patients [12–14].
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There are three commonly used urine collection methods:
the midstream clean catch technique (MSU) [15], the catheter
specimen of urine (CSU) [16], and suprapubic aspiration [17].
Sample contamination is a key concern, particularly with regard
to MSU. Our understanding is hampered by the variable defi-
nitions of “contamination” described in the literature. Some
have claimed that contamination is indicated by isolation of
microbes typical of skin flora, such as Corynebacterium and
Staphylococcus [18–20]. According to Collier et al. [21], con-
taminated urine samples are revealed by finding squamous ep-
ithelial cells on urine microscopy. Wilson and Gaido [22] de-
fined contamination as ≥2 different types of organisms at
>105 ml−1 or 1 organism at <104 ml−1. Others have reported
urine samples as contaminated, without describing the criteria
used [23, 24]. These disparities add to the confusion that affects
these diagnostic methods and there are no data available to aid
clarification. An important consideration is the substrate that
these collection methods should seek to obtain for culture.
Historically, the emphasis has been on uncontaminated urine
samples being cell-free [22]. However, contemporary studies
have shown that UTI is associated with microbial parasitisation
of urothelial cells, via surface attachment and/or intracellular
invasion [25–28]. This parasitisation stimulates urothelial cell
shedding as part of an innate immune response [27]. It has been
found that the urinary urothelial cell counts are elevated in
association with other markers of infection and that the propor-
tion of parasitised cells among the cell sediment increases dur-
ing UTIs, along with inflammatory markers and changes in the
urinary microbiome [13, 27, 29]. If the primary pathology is the
microbial invasion of urothelial cells, stimulating the concom-
itant innate immune response of increased urothelial cell shed-
ding, it is plausible that these cells would make a better sub-
strate for urine culture than would supernatants of planktonic
bacteria. This was demonstrated in our previous work [12].
Shed urothelial cells are an attractive option for study when
seeking to examine contamination with different sampling
methods. Uroplakin III (UP3), a transmembrane protein found
exclusively in the urinary tract [30], is a useful biomarker for
discerning the origin of epithelial cells in a urine sample.
Thus, it is possible to discriminate contaminating cutaneous
and vaginal squamous cells from urothelial umbrella cells
using a specific antibody against this protein with immunoflu-
orescence staining protocols.
This study consisted of two parts. The first was a compar-
ative study of the urinalysis results obtained from samples
collected by MSU and CSU. It was a random allocation,
cross-over design and the urine sampling performances were
compared using microscopic pyuria counts, epithelial cell
counts, microbial growth from spun cell sediment culture
and UP3-positive cell counts to measure contamination. The
second part of the study was a random allocation, cross-over
comparison study of contamination obtained with MSU, a
novel MSU sampling device called a “Peezy” and naturally
voided urine, in which we measured microscopic epithelial
cell counts using UP3 staining.
Materials and methods
This study was presented to the National Research Ethics
Service Committee (NRES) in Harrow, London, UK, to obtain
approval to conduct the investigation. Ethical approval was
granted, which signified that this study complied with condi-
tions that were favourable and worthy of safe research prac-
tice. Ethical approval was given subject to all clinicians in the
study having undergone training in good clinical practice
(GCP). The two-part comparative studies began in January
2013 and lasted until March 2015. Patients with LUTS attend-
ing the Community LUTS Clinic, Hornsey Central Health
Centre, London, UK, made up the participant population.
The patient sample was drawn from women diagnosed with
chronic UTI, painful bladder syndrome (PBS), overactive
bladder (OAB) and general LUTS.
Patients were given an information sheet about the study
and were offered the opportunity to ask questions and address
any concerns. The first part of the study was designed to
ascertain whether there were outcome signals that merited a
focused analysis of urinary epithelial cells in relation to sam-
ple collection. On the day of recruitment, patients were invited
to the centre, and written informed consent was obtained.
Each participant was given a unique non-identifiable number.
All patients completed a validated female LUTS questionnaire
(FLUTS and FLUTSqol) [31] and provided MSU and CSU
samples. The MSU method was accomplished by the patient
spreading her labia apart with one hand and then wiping the
urethra area with moistened wipes using the other hand [20];
the CSU was achieved by placing the patient in the lithotomy
position, inserting the urethral catheter along the urethra and
into the bladder to collect part of the urine outflow [32].
The substrate of interest in urinalysis is the inflammatory
exudate, which contains microbes, white cells, shed urothelial
cells and other debris. This may become contaminated with
external debris during collection. The collectionmethods sam-
ple different parts of the bladder urine (Fig. 1). The presence
of sediment and contaminants may be influenced by the dif-
ferent collection methods. Thus, we should seek to examine
the markers that reflect these different elements.
The urine sampling methods were randomly sequenced
and obtained with a 1-h interval between specimen collec-
tions. The specimen volume requirement was small and well
within the capacity of an hour. Urine aliquots were obtained
from the unspun specimens and these were introduced, un-
stained, into a Neubauer counting chamber; a microscope
was then used to count the white blood cells (WBCs), red
blood cells (RBCs) and epithelial cells. A sediment culture
[12] was carried out. All urine samples were collected in a
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30-ml container and spun down in a Denley refrigerated cen-
trifuge at 800 rpm (~75 relative centrifugal force [RCF]). The
remaining cell pellet was re-suspended in phosphate-buffered
saline (PBS) and three ten-fold serial dilutions were made in
PBS. A volume of 50 μl of the re-suspended pellet and dilu-
tions was plated onto chromogenic CPS3 (now renamed CPS-
Elite) agar (bioMérieux, France) [33] and dispersed evenly
using a spreader. The culture plates were incubated aerobically
at 37 °C for 24 h, followed by colony enumeration and iden-
tification using the Chrom ID™ colour chart provided.
An aliquot of spun sediment cells was collected and stained
for UP3 as described previously [27]. Briefly, epithelial cells
were adhered to a glass slide using a Shandon Cytospin
Cytocentrifuge (Thermo Scientific) with 80 μl of a urine sam-
ple for 5 min at 75 RCF. The cells were fixed with 4% form-
aldehyde in PBS for 15 min, blocked with 10% normal goat
serum for 30 min and stained for 1 h with anti-UP3 antibody.
After three washes with PBS, the secondary antibody (goat
anti-mouse IgG conjugated to Alexa-flour 488) was applied
for 40 min, washed three times and the DNA stain 4′,6-
diamidino-2-phenylindole (DAPI) was later applied for
20 min before mounting.
The second part of the study was conducted in the wake of
the first experiment and was designed to compare the quanti-
tative and qualitative properties of epithelial cells captured in
specimens obtained from an MSU, an MSU collection device
(Peezy) and a naturally voided specimen, which was a
straightforward urine sample collected by the patient in a con-
tainer without a technique. The Peezy MSU™ is a urine col-
lection method achieved by urinating into an engineered de-
vice [21]. The patients were instructed to wash their hands,
clean the genital area with wet wipes, attach the collection
bottle to the Peezy and position the Peezy MSU™ device
against the perineum whilst passing urine. As the patient be-
gan to pass urine, the first part of the stream entered the funnel
and caused a sponge valve to swell and block flow through the
main funnel exit. Once the blockage was established, a mid-
stream specimen accumulated in the funnel and was passed
out of an overflow side drain into the universal container. The
Peezy MSU™ device was then discarded into the clinical
waste bin. All urine samples were obtained using each meth-
od, through random sequencing, with one method each day
over 3 consecutive days.
This second study commenced in August 2014. Patients
recruited from the first study were asked to participate in the
second part, but fresh consent was obtained. A random code
dictated the order of sampling, which occurred on the first day
of the 3 consecutive days. For experiment 2, samples were
used to examine the epithelial cell content using the same
methods as in experiment 1.
Sample size
The sample was calculated using the G Power software pack-
age. The effect size was set as Cohen’s d = 0.55; α = 0.05;
power (1 – β err probability) = 0.8; non-centrality parameter
δ = 2.9; critical t = 2; df = 27; sample size = 28; actual power =
0.8 or 80%.
Statistical analysis
The data were not normally distributed and exhibited wide
variance; thus, to analyse quantitative measures we used the
non-parametric Friedman test, which achieves a one-way
analysis of variance by ranks. This is an alternative to the
a Catheter Specimen 
Preb -void with sediment 
accumulating at the 
bladder neck 
c Initial stream rich in 
sediment of urine
d Midstream e Terminal stream
Fig. 1 a Illustration of the fact
that the cellular sediment collects
at the bladder base under the
influence of gravity. A catheter
passes through this sediment to
obtain a specimen from the urine
that is above this substrate. The
sequence in b–e illustrates the
phases of the voiding processes.
The inflammatory sediment is
shown accumulating at the
bladder neck under the influence
of gravity. The first part of the
stream contains the largest
quantity from the sediment at the
bladder neck and this reduces
over the course of the voiding
process
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Kruskal–Wallis when analysing repeated measures. We used
the Chi-squared test to analyse the differences in proportions.
Results
Demography and symptoms
In the first study, 60 female adult patients were enrolled. The
mean age of the patient group was 60 years (SD = 12). The
patients suffered from chronic LUTS and were being treated
for chronic UTI. The demographic data are shown in Table 1
and demonstrate that the patients were suffering from signif-
icant symptoms.
Evaluation of pyuria, epithelial cells and UP3-positive
cells
To evaluate the presence of pyuria, epithelial cells and UP3-
positive cells, a total of 118 urine samples were examined
(MSU= 60, CSU = 58). The patients were at various stages
of disease. The data analysis results are shown in Tables 2, 3,
4, and 5. Microscopic pyuria counts (log10 WBC μl
−1) were
significantly lower in CSU compared with MSU. Similarly,
there were greater numbers of epithelial cells in MSU, the
majority of which were UP3-positive, indicating urothelial
origin. There was no significant difference in the proportion
of UP3-positive cells between the MSU (0.81) and CSU (0.9)
methods. If the CSU method collected a significantly less
contaminated sample, the proportion would be expected to
be significantly higher with the CSU method. These results
suggest thatMSUmight enrich a urine sample for urinary tract
cell sediment compared with the CSU, without increased or
appreciable contamination.
Evaluation of culture results
All 118 urine samples were sent to the National Health Service
(NHS) laboratory for routine culture (plating of 1 μl of urinary
supernatant) and of these, 110 specimens were reported as
“negative” (defined as below the 105cfu/ml threshold) or
“mixed growth”, which is commonly reported for chronic
UTI patients [12, 13, 37]. Thus, in addition to routine culture,
we enriched infected cells by performing a spun sediment
culture [12] on the samples. Table 6 describes the occurrences
of the top 90% of isolates across all patients cultured from the
three different specimen collection methods. The data show
that the spun sediment culture performed on MSU samples
was the most productive method and the technique performed
with CSU samples had significantly more negative results.
The standard NHS culture method was far less productive
whether it was from MSU or CSU; taken together, these re-
sults emphasise the insensitivities of both collection methods.
The CSU seems to trade purity for sensitivity.
Evaluation of UP3-positive cells, comparing MSU,
Peezy MSU™ and natural void
Thirty-one patients were enrolled in this study, which used the
UP3-positive properties of urothelial cells to identify the ori-
gin of epithelial cells, given that skin and vaginal cells are
UP3-negative. The mean age of the patients was 62 (SD =
10). In total, 93 non-invasive urine samples were collected
by MSU, Peezy MSU™ and natural voided urine. Tables 7,
8, and 9 reports the analysis of the UP3-positive cells. The
mean count of UP3-positive cells from the natural void meth-
od was greatest compared with the MSU and Peezy MSU™.
Thus, natural void achieved the greatest abundance of the
target substrate. The lowest UP3-positive cell count was ob-
served with the Peezy technique; thus, this method captured
the substrate the least. The UP3-negative cells were sparse,
with no difference between specimen collection techniques
(Table 7, 8, and 9). Thus, the proportion of all cells that were
UP3-positive did not differ between the sampling methods,
which implies that, contrary to assumptions, contamination
by extra-urinary tract cells is not influenced by the sampling
technique and was low overall.
Discussion
The purpose of this study was to measure contamination and
substrate content for four different methods of obtaining urine
samples. It also used the fact that urothelial cells can be dis-
tinguished from squamous epithelial cells by UP3 staining.
This enabled measurement of contamination by the extra-
urinary milieu compromising these various methods. The pro-
portion of UP3-positive cells found in MSU samples was
Table 1 The average symptom scores and quality of life scores for patients who attended the Community Lower Urinary Tract Symptom (LUTS)
Clinic with LUTS
Participants Mean age Mean urgency [34] score
(maximum= 64)
Normal = 0 [35]
Mean pain score [34]
(maximum= 12)
Normal = 0 [35]
FLUTS [34] (without
urgency and pain)
(maximum= 149)
Normal = 0 [35]
FLUTSqol [36]
(maximum= 288)
Normal = N/A
Patients 60 (SD = 12) 16 (SD = 11) 10 (SD = 7) 64 (SD = 40) 151 (SD = 75)
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previously reported as 75% (Q1 = 68, Q3 = 78.5) by Horsley
et al [27]. This study had a similar outcome, and has extended
this to three other sample collection methods. Taken together
with a wide body of literature demonstrating that urothelial
cell shedding is a common innate immune response to infec-
tion, this study suggests that the widely held assumption that
epithelial cells in a urine sample indicate contamination might
need to be revised [26]. The sample collection method did
influence the absolute epithelial cell counts, the lowest num-
ber with CSU samples (Fig. 1a) and the greatest number with
natural void (Fig. 1c), during which the bladder contracts and
collapses to eliminate bladder urinary substrate. The Peezy
device seemed to do what it claimed, achieving a sample of
fewer cells and very few uroplakin-negative cells. However,
the sediment trapped in the sponge valve of the Peezy device
may, counter-intuitively, prove to be a richer substrate for
microbiological investigation, as bacteria are known to adhere
to and colonise the urothelial cells.
The rationale of midstream sampling has always been the
avoidance of contamination. This was never properly tested
and relied on assumptions. In this experiment we were able to
analyse contamination directly by using UP3 staining of the
epithelial cells as a proxy, and we found that contrary to what
has been assumed, the majority of epithelial cells in all sam-
ples originated from the urinary tract.
The standard NHS MSU culture achieved a very small
number of positive cultures, in contrast to the spun sediment
cultures, despite the patients exhibiting significantly fewer
urinary tract symptoms; this discrepancy has been reported
previously by our team and others [38]. Urinary microscopic
detection of pyuria and increased urothelial cell shedding pro-
vided strong evidence for the presence of UTI. The sediment
culture generated a greater abundance of isolates. However,
given that healthy urine is known to harbour many species of
bacteria, including known uropathogens [39], it is not known
whether these microbes are pathogenic or harmless commen-
sals, a problem affecting all current urinary microbial detec-
tion methods.
The symptomatic measurements pain, urgency, FLUTS
and LUTSqol were concordant with the pyuria and culture
data [13]. It should be appreciated that CSU sampling missed
a pathological signal in a significant proportion of patients
with appropriate symptoms, pyuria and urothelial cell shed-
ding. Compared with CSU, the MSU technique provided a
more substantial sample of the inflammatory sediment. UTI
involves colonisation of the urothelial cells by pathogenic
microbes [12, 27, 40]. The innate immune response to this
microbial colonisation is increased urothelial cell shedding,
which may be promoted by mast cells [41]. The shed cells
may be colonised or unaffected, but the proportion of
parasitised cells in the face of infection would be expected
to increase [42]. This sediment, a mixture of white cells, epi-
thelial cells and debris, is likely to collect under the influence
of gravity at the bladder base, forming a sampling target that
should not be influenced by dilution effects. This is made
evident by the characteristic milky quality of the terminal flow
when a catheter is used to drain an infected bladder. A cathe-
ter, as well as a suprapubic stab, samples urine above this
collection at the bladder base (Fig. 1a), and therefore contains
fewer epithelial cells, white cells and microbes, a point
reflected in the data reported here. Thus, a CSU sample may
be an inferior option because it may miss a substantial amount
of the pathology.
With the advent of more sensitive genomic technology, a
number of groups have reported that the healthy bladder is not
sterile, and that polymicrobial colonisation is the norm in both
healthy and infected bladders [12, 14, 43]. Polymicrobial
Table 2 Evaluation of microscopic pyuria for the midstream urine
(MSU) and catheter specimen urine (CSU) samples
Analysis Pyuria count MSU
(WBCs μl−1)
Pyuria count CSU
(WBCs μl−1)
p
Mean 65 24 0.001
Median 0 0
Standard deviation 321 148
WBCs white blood cells
Table 3 Evaluation of microscopic urinary epithelial cells for the
midstream urine (MSU) and catheter specimen urine (CSU) samples
Analysis Epithelial cells
(μl−1) MSU
Epithelial cells
CSU (μl−1)
p
Mean 21 2 0.002
Median 2 0
Standard deviation 103 4
Table 4 Evaluation of uroplakin-positive cells (UP3) for the midstream
urine (MSU) and catheter specimen urine (CSU) samples
Analysis UP3 cells
(cells/80 μl) MSU
UP3 cells
(cells/80 μl) CSU
p
Mean 17 5 0.006
Median 3 1
Standard deviation 30 12
Table 5 Evaluation of the proportion of uroplakin-positive cells (UP3)
for the MSU and CSU sample
Analysis Proportion of cells
UP3-positive MSU
Proportion of cells
UP3-positive CSU
p
Mean 0.81 0.9 0.98
Median 1 1
Standard deviation 0.3 0.2
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growth in urine specimens has been associated with LUTS in
a recent study of similar patients [21]. Indeed, the sediment
cultures carried out on urine samples collected by MSU and
CSU in this study also demonstrated polymicrobial growth. In
patients with symptoms of UTI, the species dispersion ismuch
wider than in asymptomatic controls [12, 18, 43–45]. At this
time it is not known what species of these mixes are respon-
sible for the disease. In this study, the data on the UP3-positive
cells argued against the common assumption that
polymicrobial results and/or epithelial cells are pointers to
contamination. A recent study has shown the isolation of a
different microbial population using the Peezy compared with
one isolated from peri-urethral swabs, based on the assump-
tion of peri-urethral contamination of MSU samples [46].
The natural void provided the greatest number of urothelial
cells and even in this situation, UP3 analysis did not show
evidence of increased contamination, which contradicts
long-held assumptions about urine sampling. The natural void
captures the first part of the urinary stream; the influence of
gravity would encourage such samples to contain a larger
proportion of the sediment because of settlement at the blad-
der base (Fig. 1b). By avoiding the initial stream, the MSU
and Peezy MSU™ methods collected samples containing
fewer cells, the Peezy MSU™ providing the clearest speci-
mens (Fig. 1d). The remaining urine in the bladder proceeds
with a terminal flow, with very few bladder sediments (Fig.
1e).
The Peezy MSU™ device works with a sponge in the fun-
nel exit, which inflates gradually on contact with the first part
of the urinary stream, eventually blocking the outflow so that
the remainder of the stream escapes by a side channel into a
collecting tube. Thus, the bulk of the sediment deposit from
the bladder neck would be expected to be trapped in the
sponge. If the bladder base sediment is indeed, as recent work
suggests, the best specific target for diagnostic analysis, so is
the content of the sponge. As matters stand, the PeezyMSU™
achieves what it sets out to do and provides an MSU sample
Table 6 Results of the spun urinary sediment culture carried out at the community LUTS clinic laboratory and NHS laboratory
Number (%)
culturing E coli
Number
culturing
Enterococcus
Number
culturing
Streptococcus
Number
culturing
Staphylococcus
Number
culturing
Proteus
Number
culturing
yeast
Number with
no growth
Total
MSU spun sediment
culture, LUTS
laboratory
18 (30) 13 (22) 12 (20) 5 (8) 8 (13) 4 (7) 0 (0) 60
CSU spun sediment
culture, LUTS
laboratory
4 (7) 15 (26) 1 (2) 0 2 (3) 5 (9) 31 (53) 58
NHS MSU
laboratory results
1 (1) 2 (2) 1 (1) 0 0 1 (1) 100 (95) 105
NHS CSU
laboratory results
1 (8) 2 (15) 0 0 0 0 10 (77) 13
Table 7 Evaluation of UP3-positive cells frommidstream urine (MSU),
Peezy MSU™ and natural void, which are all non-invasive urine collec-
tion methods
UP3-
positive
cells
MSU
(cells/
80 μl)
UP3-
positive
cells
Peezy
MSU™
(cells/
80 μl)
UP3-positive
cells Natural
void (cells/
80 μl)
p
Analysis
Mean 8 3 16 0.001
Median 2 2 3
Standard
deviation
17 8 27
Test statistics
N 31
Chi-squared
14.-
041
df 2
Table 8 Evaluation of UP3-negative cells from midstream urine
(MSU), Peezy MSU™ and natural void, which are all non-invasive urine
collection methods
UP3-
negative
cells MSU
(cells/
80 μl)
UP3-negative
cells Peezy
MSU™
(cells/80 μl)
UP3-
negative
cells natural
void (cells/
80 μl)
p
Analysis
Mean 1 0.87 3 0.325
Median 0 0 0
Standard
deviation
2 2 9
Test statistics
N 31
Chi-squared 2.250
df 2
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free of early stream content, but in achieving that goal, it is less
effective at capturing the sediment at the base of the bladder.
In conclusion, this study, supported by previous findings
[27], suggests that epithelial cells might be a legitimate com-
ponent of the urinary sample and are not derived from the peri-
urethral area. Naturally voided urine provides the richest
source of urinary sediment and may be the better sampling
method for urinalysis in the face of LUTS. By comparison, the
MSU, and particularly the CSU, provide inferior samples,
because the pathological cellular exudate is excluded.
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